Cargando…
Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses
BACKGROUND: We aimed to establish a bipolar disorder biobank to serve as a resource for clinical and biomarker studies of disease risk and treatment response. Here, we describe the aims, design, infrastructure, and research uses of the biobank, along with demographics and clinical features of the fi...
Autores principales: | Frye, Mark A, McElroy, Susan L, Fuentes, Manuel, Sutor, Bruce, Schak, Kathryn M, Galardy, Christine W, Palmer, Brian A, Prieto, Miguel L, Kung, Simon, Sola, Christopher L, Ryu, Euijung, Veldic, Marin, Geske, Jennifer, Cuellar-Barboza, Alfredo, Seymour, Lisa R, Mori, Nicole, Crowe, Scott, Rummans, Teresa A, Biernacka, Joanna M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478187/ https://www.ncbi.nlm.nih.gov/pubmed/26105627 http://dx.doi.org/10.1186/s40345-015-0030-4 |
Ejemplares similares
-
Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder
por: Markota, Matej, et al.
Publicado: (2018) -
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
por: Cuéllar-Barboza, Alfredo B., et al.
Publicado: (2020) -
Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities
por: Prieto, M L, et al.
Publicado: (2016) -
Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction
por: Jia, Yun-Fang, et al.
Publicado: (2017) -
Antidepressant-Associated Treatment Emergent Mania: A Meta-Analysis to Guide Risk Modeling Pharmacogenomic Targets of Potential Clinical Value
por: Nuñez, Nicolas A., et al.
Publicado: (2023)